SMAD3 and osteosarcoma: Taken together, we demonstrate that miR-16-5p expression is downregulated in osteosarcoma and that overexpression of miR-16-5p inhibits the proliferation, migration, and invasion of osteosarcoma cells by targeting Smad3.